82 related articles for article (PubMed ID: 7800911)
1. [The toxicity of slow-release verapamil and chronic kidney disease].
Huelmos A; Alegría E; Vázquez C
Rev Esp Cardiol; 1994 Nov; 47(11):780. PubMed ID: 7800911
[No Abstract] [Full Text] [Related]
2. Acute toxic effects of sustained-release verapamil in chronic renal failure.
Pritza DR; Bierman MH; Hammeke MD
Arch Intern Med; 1991 Oct; 151(10):2081-4. PubMed ID: 1843183
[TBL] [Abstract][Full Text] [Related]
3. Verapamil toxicity: an unusual case report and review of the literature.
Batalis NI; Harley RA; Schandl CA
Am J Forensic Med Pathol; 2007 Jun; 28(2):137-40. PubMed ID: 17525564
[TBL] [Abstract][Full Text] [Related]
4. Junctional bradycardia with verapamil in renal failure--care required even with mild hyperkalaemia.
Hegazi MO; Aldabie G; Al-Mutairi S; El Sayed A
J Clin Pharm Ther; 2012 Dec; 37(6):726-8. PubMed ID: 22568727
[TBL] [Abstract][Full Text] [Related]
5. Massive overdose of sustained-release verapamil: a case report and review of literature.
Ashraf M; Chaudhary K; Nelson J; Thompson W
Am J Med Sci; 1995 Dec; 310(6):258-63. PubMed ID: 7503108
[TBL] [Abstract][Full Text] [Related]
6. [Verapamil and hypertension--(multicenter study of the efficacy and tolerance of delayed-action verapamil in the treatment of essential hypertension)].
Kreuter U; Mühlemann M; Vogt E; Wohlwend MC
Rev Med Suisse Romande; 1990 Jun; 110(6):551-8. PubMed ID: 2195624
[No Abstract] [Full Text] [Related]
7. Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease.
White WB; Johnson MF; Anders RJ; Elliott WJ; Black HR
Am Heart J; 2001 Dec; 142(6):1010-5. PubMed ID: 11717605
[TBL] [Abstract][Full Text] [Related]
8. [Verapamil-associated liver injury].
Odeh M; Oliven A
Harefuah; 1998 Jan; 134(1):36-7. PubMed ID: 9517278
[TBL] [Abstract][Full Text] [Related]
9. [Poisoning by delayed-release verapamil in renal insufficiency patients].
Daroca Pérez R; Alfaro Olea A; San Román Lazcano FJ; Jiménez Santolaya C
Med Clin (Barc); 1993 Oct; 101(14):557-8. PubMed ID: 8231404
[No Abstract] [Full Text] [Related]
10. Verapamil for hypertension.
Med Lett Drugs Ther; 1987 Apr; 29(737):37-8. PubMed ID: 3561323
[No Abstract] [Full Text] [Related]
11. The efficacy of a slow-release formulation of verapamil.
Taylor SH
Br J Clin Pract Suppl; 1985 Jun; 42():34. PubMed ID: 3929826
[No Abstract] [Full Text] [Related]
12. Studies with sustained-release verapamil in essential hypertension.
Silke B
Br J Clin Pract Suppl; 1988 Apr; 60():53-7. PubMed ID: 3151272
[No Abstract] [Full Text] [Related]
13. [Toxic effects of verapamil in chronic renal failure].
Tomás S; Duaso E; Llibre J
Med Clin (Barc); 1994 Apr; 102(12):478. PubMed ID: 8208003
[No Abstract] [Full Text] [Related]
14. [Study of the mechanism of regression of left ventricular hypertrophy in hypertension treated with slow-release verapamil].
Li G; Sun M; Zhou H
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(5):419-21, 424. PubMed ID: 10073024
[TBL] [Abstract][Full Text] [Related]
15. Verapamil deleterious effects in chronic renal failure.
Váquez C; Huelmos A; Alegría E; Errasti P; Purroy A
Nephron; 1996; 72(3):461-4. PubMed ID: 8852497
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of arterial hypertension in chronic renal insufficiency with slow-release nifedipine].
Ambroso GC; Como G; Ponticelli C
Minerva Nefrol; 1982; 29(3):151-8. PubMed ID: 7145215
[No Abstract] [Full Text] [Related]
17. Intravenous fat emulsion therapy for intentional sustained-release verapamil overdose.
Young AC; Velez LI; Kleinschmidt KC
Resuscitation; 2009 May; 80(5):591-3. PubMed ID: 19282085
[TBL] [Abstract][Full Text] [Related]
18. Securon SR: sustained-release verapamil.
Drug Ther Bull; 1987 Jun; 25(12):47-8. PubMed ID: 3608822
[No Abstract] [Full Text] [Related]
19. Modified release verapamil induced cardiogenic shock.
Nanda U; Ashish A; Why HJ
Emerg Med J; 2005 Nov; 22(11):832-3. PubMed ID: 16244356
[TBL] [Abstract][Full Text] [Related]
20. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
